DARING-B: discontinuation of effective entecavir or tenofovir therapy in non-cirrhotic HBeAg-negative chronic hepatitis B patients: a prospective Greek study
Papatheodoridis, G, Rigopoulou, E, Papatheodoridi, M, Zachou, K, Xourafas, V, Gatselis, N, Vlachogiannakos, J, Dalekos, G
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
5044 The role of cryotherapy on fentanyl use in breast cancer patients
Xourafas, V, Heras, P, Hatzopoulos, A, Karagiannis, S
Published in European journal of cancer supplements (2009)
Published in European journal of cancer supplements (2009)
Get full text
Journal Article
DARING-B: discontinuation of effective entecavir or tenofovir disoproxil fumarate long-term therapy before HBsAg loss in non-cirrhotic HBeAg-negative chronic hepatitis B
Papatheodoridis, George V, Rigopoulou, Eirini I, Papatheodoridi, Margarita, Zachou, Kalliopi, Xourafas, Vassilios, Gatselis, Nikolaos, Hadziyannis, Emilia, Vlachogiannakos, John, Manolakopoulos, Spilios, Dalekos, George N
Published in Antiviral therapy (01.01.2018)
Published in Antiviral therapy (01.01.2018)
Get full text
Journal Article
PS-043 - DARING-B: discontinuation of effective entecavir or tenofovir therapy in non-cirrhotic HBeAg-negative chronic hepatitis B patients: a prospective Greek study
Papatheodoridis, G., Rigopoulou, E., Papatheodoridi, M., Zachou, K., Xourafas, V., Gatselis, N., Vlachogiannakos, J., Dalekos, G.
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
PS-159 - Rates and predictors of HBsAg loss after discontinuation of effective long-term Entecavir or Tenofovir therapy in noncirrhotic HBeAg-negative chronic hepatitis B patients: Results from the DARING-B prospective Greek study
Papatheodoridis, M., Rigopoulou, E., Hadziyannis, E., Kalliopi, Z., Xourafas, V., Lyberopoulou, A., Gatselis, N., Vlachogiannakos, I., Manolakopoulos, S., Dalekos, G., Papatheodoridis, G.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
Rates and predictors of HBsAg loss after discontinuation of effective long-term Entecavir or Tenofovir therapy in noncirrhotic HBeAg-negative chronic hepatitis B patients: Results from the DARING-B prospective Greek study
Papatheodoridis, M., Rigopoulou, E., Hadziyannis, E., Kalliopi, Z., Xourafas, V., Lyberopoulou, A., Gatselis, N., Vlachogiannakos, I., Manolakopoulos, S., Dalekos, G., Papatheodoridis, G.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article